Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Net Cash Flow: 2013-2024

Historic Net Cash Flow for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $73.6 million.

  • Surgery Partners' Net Cash Flow fell 66265.06% to -$46.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.4 million, marking a year-over-year decrease of 2957.75%. This contributed to the annual value of $73.6 million for FY2024, which is 18459.77% up from last year.
  • Per Surgery Partners' latest filing, its Net Cash Flow stood at $73.6 million for FY2024, which was up 18459.77% from -$87.0 million recorded in FY2023.
  • In the past 5 years, Surgery Partners' Net Cash Flow registered a high of $225.2 million during FY2020, and its lowest value of -$107.0 million during FY2022.
  • Over the past 5 years, Surgery Partners' median Net Cash Flow value was $71.7 million (recorded in 2021), while the average stood at $35.3 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first soared by 34585.15% in 2020, then crashed by 24923.29% in 2022.
  • Surgery Partners' Net Cash Flow (Annual) stood at $225.2 million in 2020, then tumbled by 68.16% to $71.7 million in 2021, then tumbled by 249.23% to -$107.0 million in 2022, then grew by 18.69% to -$87.0 million in 2023, then skyrocketed by 184.6% to $73.6 million in 2024.
  • Its Net Cash Flow stands at $73.6 million for FY2024, versus -$87.0 million for FY2023 and -$107.0 million for FY2022.